Delivery Order SPE2DB22D3501-SPE2DB25FVK68
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.62 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 31, 2025. This award was made on a firm fixed price basis with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,352.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 20, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,548.17 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic used in military and federal healthcare settings. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and the product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $1,727.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of June 20, 2025. This non-set-aside competitive award was issued on June 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,527.09 by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, an intravenous antibiotic commonly used in military and federal healthcare settings. The contract is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This award was made through open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a common antibiotic used across military and federal healthcare systems. This firm fixed-price delivery order, valued at $6,774.10, was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,569.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 29, 2025. This contract employs firm fixed price pricing and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and a key distribution hub for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,142.63 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $11,794.85 to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 5, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order, valued at $4,324.77, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026. The award was...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVK68Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,796.66 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of April 25, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order exemplifies AmerisourceBergen's extensive role as a pharmaceutical distributor within the DLA's medical supply chain. The company holds a prime $999.999 billion IDC (designated SPE2DX) through December 2026 that enables it to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's contract portfolio with DLA demonstrates its capacity to fulfill federal requirements across multiple therapeutic domains, from specialty medications to generic drugs, supporting various government healthcare entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/24/25 |